Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Cost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income - MinorityNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Select Medical Holdings (SEM) EBIT (2016 - 2025)

Historic EBIT for Select Medical Holdings (SEM) over the last 17 years, with Q3 2025 value amounting to $73.0 million.

  • Select Medical Holdings' EBIT rose 3289.5% to $73.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $293.3 million, marking a year-over-year increase of 29721.71%. This contributed to the annual value of $268.3 million for FY2024, which is 40.15% up from last year.
  • As of Q3 2025, Select Medical Holdings' EBIT stood at $73.0 million, which was up 3289.5% from $86.5 million recorded in Q2 2025.
  • Over the past 5 years, Select Medical Holdings' EBIT peaked at $284.0 million during Q2 2021, and registered a low of -$173.4 million during Q4 2023.
  • Over the past 5 years, Select Medical Holdings' median EBIT value was $104.0 million (recorded in 2022), while the average stood at $87.7 million.
  • Per our database at Business Quant, Select Medical Holdings' EBIT surged by 13759.43% in 2021 and then crashed by 32139.18% in 2022.
  • Quarter analysis of 5 years shows Select Medical Holdings' EBIT stood at $77.5 million in 2021, then crashed by 321.39% to -$171.7 million in 2022, then fell by 1.0% to -$173.4 million in 2023, then soared by 112.16% to $21.1 million in 2024, then soared by 245.92% to $73.0 million in 2025.
  • Its last three reported values are $73.0 million in Q3 2025, $86.5 million for Q2 2025, and $112.7 million during Q1 2025.